STOCK TITAN

Cresco Labs and Khalifa Kush Expand Partnership to Bring Brand’s Premium Products to Massachusetts Cannabis Consumers

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
partnership
Rhea-AI Summary
Cresco Labs expands partnership with Khalifa Kush to exclusively cultivate, manufacture, and distribute premium cannabis products in Massachusetts. Flower and pre-rolls will be available at Sunnyside dispensaries starting July 22.
Positive
  • Cresco Labs expands partnership with Khalifa Kush in Massachusetts market, bringing top-quality products to Sunnyside stores. Massachusetts is an important growth market for Cresco Labs. Exclusive genetics KK and Khalifa Mints will be available for purchase.
Negative
  • None.

CHICAGO--(BUSINESS WIRE)-- Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”), a vertically integrated, multi-state operator and the cannabis industry’s No. 1 producer of branded products, today announced the expansion of a partnership with Khalifa Kush to exclusively cultivate, manufacture and distribute the cannabis brand’s premium products in Massachusetts. Wiz Khalifa is the multi-platinum-selling, GRAMMY® and Golden Globe® Award-nominated recording artist behind Khalifa Kush. Flower and pre-rolls, including Khalifa Kush’s widely recognized KK and Khalifa Mints strains, will be available for purchase starting July 22 exclusively at Sunnyside dispensaries in Fall River, Framingham, Leicester and Worcester. An expanded product line is expected to arrive at additional retail partners soon.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230720984317/en/

Through an exclusive partnership between Cresco Labs and the Khalifa Kush brand, flower and pre-rolls from Khalifa Kush will be available for sale starting July 22 at Sunnyside stores throughout Massachusetts. (Photo: Business Wire)

Through an exclusive partnership between Cresco Labs and the Khalifa Kush brand, flower and pre-rolls from Khalifa Kush will be available for sale starting July 22 at Sunnyside stores throughout Massachusetts. (Photo: Business Wire)

“We’re thrilled to continue collaborating with the Khalifa Kush brand in the Massachusetts market after a successful partnership launch with them in California that has grown to include new, bestselling products,” said Charlie Bachtell, CEO and Co-founder of Cresco Labs. “Massachusetts, where we have the number one share and bestselling flower and concentrates branded portfolio, continues to be an important growth market for Cresco Labs, and we couldn’t be more excited to bring Khalifa Kush’s top-quality products to our Sunnyside stores and excite and delight our customers on the East Coast.”

“We are excited to launch the Khalifa Kush brand in our tenth state and second alongside the Cresco team, bringing our exclusive genetics, KK and Khalifa Mints, to the people of Massachusetts. Grown by one of the industry's best cultivators, it’s everything the East Coast needs,” said Wiz Khalifa.

About Cresco Labs

Cresco Labs is one of the largest vertically integrated, multi-state cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco®, High Supply®, Mindy’s™, Good News®, Remedi™, Wonder Wellness Co.® and FloraCal Farms®. Cresco Labs’ national dispensary brand, Sunnyside®, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED™, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

Facebook: Cresco Labs
Twitter: Cresco Labs
LinkedIn: Cresco Labs

About Khalifa Kush

Khalifa Kush is a Los Angeles and Pittsburgh based cannabis, clothing, and accessories brand founded by global icon Wiz Khalifa. Khalifa Kush products were first commercialized in the U.S. in 2015, and has achieved continued growth and success by focusing on world-class quality and highly sought-after products, powered by proprietary genetics. The Khalifa Kush brand offers a full lineup of flower, pre-rolls, vapes, edibles, and concentrates. Khalifa Kush is now available in select markets including Arizona, California, Florida, Maryland, Michigan, Nevada, Oregon, and Pennsylvania. Learn more about the upcoming Massachusetts launch and shop apparel at KHALIFAKUSH.COM.

Media:

Jason Erkes, Cresco Labs

Chief Communications Officer

press@crescolabs.com

Investors:

Megan Kulick, Cresco Labs

Senior Vice President, Investor Relations

investors@crescolabs.com

For general Cresco Labs inquiries:

312-929-0993

info@crescolabs.com

Media:

Khalifa Kush

Press@khalifakush.com

Source: Cresco Labs

Cresco Labs is expanding its partnership with Khalifa Kush to exclusively cultivate, manufacture, and distribute premium cannabis products in Massachusetts.

Flower and pre-rolls from Khalifa Kush will be available for purchase starting July 22 at Sunnyside dispensaries in Massachusetts.

The exclusive genetics being offered are KK and Khalifa Mints strains.
Cresco Labs Inc.

OTC:CRLBF

CRLBF Rankings

CRLBF Latest News

CRLBF Stock Data

Medicinal and Botanical Manufacturing
Manufacturing
Link
Pharmaceuticals: Other, Health Technology, Process Industries, Agricultural Commodities/Milling
US
Chicago

About CRLBF

cresco labs llc is an illinois medical cannabis company, licensed to develop and operate medical cannabis cultivation centers in police districts 5, 9 and 21, according to illinois’ office of the governor. cresco labs exceeded the state’s rigorous qualifying standards, receiving the highest scores of any cultivation center applicant to obtain three of 18 total awarded cultivation licenses as part of the illinois medical cannabis pilot program.